These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 29136616)

  • 1. No Relapse of Calcineurin Inhibitor-Associated Thrombotic Microangiopathy after Discontinuation of Eculizumab.
    Neumann T; Plis A; Weigel M; Stracke S; Friesecke S; Stecher SS; Schneidewind L; Busemann C; Schmidt CA; Krüger WH
    Acta Haematol; 2017; 138(4):194-197. PubMed ID: 29136616
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful use of eculizumab in a patient with post-transplant thrombotic microangiopathy.
    Peffault de Latour R; Xhaard A; Fremeaux-Bacchi V; Coppo P; Fischer AM; Helley D; Socié G
    Br J Haematol; 2013 Apr; 161(2):279-80. PubMed ID: 23294015
    [No Abstract]   [Full Text] [Related]  

  • 3. Belatacept and Eculizumab for Treatment of Calcineurin Inhibitor-induced Thrombotic Microangiopathy After Kidney Transplantation: Case Report.
    Merola J; Yoo PS; Schaub J; Smith JD; Rodriguez-Davalos MI; Tichy E; Mulligan DC; Asch W; Formica R; Kashgarian M; Kulkarni S
    Transplant Proc; 2016 Nov; 48(9):3106-3108. PubMed ID: 27932157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case Report: Carfilzomib-induced Thrombotic Microangiopathy With Complement Activation Treated Successfully With Eculizumab.
    Bhutani D; Assal A; Mapara MY; Prinzing S; Lentzsch S
    Clin Lymphoma Myeloma Leuk; 2020 Apr; 20(4):e155-e157. PubMed ID: 32098724
    [No Abstract]   [Full Text] [Related]  

  • 5. Carfilzomib: A cause of drug associated thrombotic microangiopathy.
    Qaqish I; Schlam IM; Chakkera HA; Fonseca R; Adamski J
    Transfus Apher Sci; 2016 Jun; 54(3):401-4. PubMed ID: 27017313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eculizumab in Transplant-Associated Thrombotic Microangiopathy.
    Dhakal P; Giri S; Pathak R; Bhatt VR
    Clin Appl Thromb Hemost; 2017 Mar; 23(2):175-180. PubMed ID: 26259912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two cases of kidney transplantation-associated thrombotic microangiopathy successfully treated with eculizumab.
    Ikeda T; Okumi M; Unagami K; Kanzawa T; Sawada A; Kawanishi K; Omoto K; Ishida H; Tanabe K
    Nephrology (Carlton); 2016 Jul; 21 Suppl 1():35-40. PubMed ID: 26970541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcineurin inhibitor toxicity in de novo thrombotic microangiopathy-Is the culprit what we think it is?
    Petr V; Zahradka I; Viklicky O
    Am J Transplant; 2024 Sep; 24(9):1708-1709. PubMed ID: 38677652
    [No Abstract]   [Full Text] [Related]  

  • 9. Cytomegalovirus-induced thrombotic microangiopathy after renal transplant successfully treated with eculizumab: case report and review of the literature.
    Java A; Edwards A; Rossi A; Pandey R; Gaut J; Delos Santos R; Miller B; Klein C; Brennan D
    Transpl Int; 2015 Sep; 28(9):1121-5. PubMed ID: 25864519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombotic microangiopathy associated with tacrolimus in lung transplantation.
    Reig Mezquida JP; Jover AS; Ansótegui Barrera E; Escrivá Peiró J; Pastor Colom MD; Pastor Guillem J
    Arch Bronconeumol; 2015 May; 51(5):e23-4. PubMed ID: 25138798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recovery from life-threatening transplantation-associated thrombotic microangiopathy using eculizumab in a patient with very severe aplastic anemia.
    Okano M; Sakata N; Ueda S; Takemura T
    Bone Marrow Transplant; 2014 Aug; 49(8):1116-8. PubMed ID: 24820211
    [No Abstract]   [Full Text] [Related]  

  • 12. Is complement blockade an acceptable therapeutic strategy for hematopoietic cell transplant-associated thrombotic microangiopathy?
    Dhakal P; Bhatt VR
    Bone Marrow Transplant; 2017 Mar; 52(3):352-356. PubMed ID: 27775697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement as the enabler of carfilzomib-induced thrombotic microangiopathy.
    Blasco M; Martínez-Roca A; Rodríguez-Lobato LG; Garcia-Herrera A; Rosiñol L; Castro P; Fernández S; Quintana LF; Cibeira MT; Bladé J; Fernández de Larrea C; Tovar N; Jimenez R; Poch E; Guillen E; Campistol JM; Carreras E; Diaz-Ricart M; Palomo M
    Br J Haematol; 2021 Apr; 193(1):181-187. PubMed ID: 32469083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De Novo Thrombotic Microangiopathy Immediately After Kidney Transplant in Patients Without Apparent Risk Factors.
    Patel A; Knorr JP; Campos S; Khanmoradi K; Zaki RF; Bradauskaite G
    Exp Clin Transplant; 2016 Apr; 14(2):230-4. PubMed ID: 26030297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variable Eculizumab Clearance Requires Pharmacodynamic Monitoring to Optimize Therapy for Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation.
    Jodele S; Fukuda T; Mizuno K; Vinks AA; Laskin BL; Goebel J; Dixon BP; Chima RS; Hirsch R; Teusink A; Lazear D; Lane A; Myers KC; Dandoy CE; Davies SM
    Biol Blood Marrow Transplant; 2016 Feb; 22(2):307-315. PubMed ID: 26456258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of acute thrombotic microangiopathy by eculizumab after combined lung and kidney transplantation.
    Commereuc M; Karras A; Amrein C; Boussaud V; Sberro-Soussan R; Guillemain R; Bacchi VF; Thervet E
    Transplantation; 2013 Oct; 96(8):e58-9. PubMed ID: 24132114
    [No Abstract]   [Full Text] [Related]  

  • 17. [Gemcitabine-induced thrombotic microangiopathy: Can we improve screening and treatment?].
    Charmetant X; Jolivot A; Fournier T; Puthet JC; Cassier P; Lemoine S; Juillard L
    Nephrol Ther; 2017 Jun; 13(4):251-254. PubMed ID: 28499586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombotic Microangiopathy after Allogeneic Stem Cell Transplantation: A Comparison of Eculizumab Therapy and Conventional Therapy.
    Bohl SR; Kuchenbauer F; von Harsdorf S; Kloevekorn N; Schönsteiner SS; Rouhi A; Schwarzwälder P; Döhner H; Bunjes D; Bommer M
    Biol Blood Marrow Transplant; 2017 Dec; 23(12):2172-2177. PubMed ID: 28860002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombotic microangiopathy syndromes.
    Zakarija A
    Cancer Treat Res; 2009; 148():115-36. PubMed ID: 19377922
    [No Abstract]   [Full Text] [Related]  

  • 20. [The revolution of monoclonal antibodies in the treatment of thrombotic microangiopathy].
    Sauvètre G; Grange S; Froissart A; Veyradier A; Coppo P; Benhamou Y
    Rev Med Interne; 2015 May; 36(5):328-38. PubMed ID: 25547956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.